No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
217 |
4. Check minimum number of eventsNone |
217 |
5. Include endpointsNone |
217 |
6. Filter based on genotype QC (FinnGen only) |
209 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of pancreas
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, including Hilmo
- Malignant neoplasm of digestive organs
- Solid cancers, helper endpoint
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 209 | 99 | 110 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.05 |
| Median age at first event (years) | 62.12 | 59.84 | 64.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 217
- Matched controls
- 2170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
329.0
275.9
131
10
130
Kela drug reimbursment
Malignant tumour
+∞
149.9
126
*
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
102.9
133.1
70
10
WX302
NOMESCO Finland
Thoracal epidural anesthesy
59.4
123.1
72
18
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
102.4
90
*
JN4AD
NOMESCO Finland
Body CT examination
18.4
78.3
72
57
H01CB03
ATC
lanreotide; parenteral
+∞
75.5
68
*
JN4BD
NOMESCO Finland
Extensive body CT
19.8
73.9
64
45
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
72.0
65
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
72.0
65
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
35.0
71.2
47
17
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
35.0
71.2
47
17
A03FA01
ATC
metoclopramide; systemic, rectal
11.6
71.0
100
149
L01BC06
ATC
capecitabine; oral
+∞
67.2
61
*
A04AA02
ATC
granisetron; systemic, transdermal
856.6
66.7
62
*
L01AX03
ATC
temozolomide; systemic
+∞
66.1
60
*
A04AA01
ATC
ondansetron; systemic, rectal
28.8
62.4
44
19
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
60.3
55
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
60.3
55
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
30.4
58.2
40
16
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
58.0
53
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
58.0
53
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
127.8
54.9
57
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
10.6
53.5
71
95
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
52.2
48
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
15.9
50.2
47
37
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
44.3
41
*
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
+∞
44.3
41
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.3
41
*
H01CB02
ATC
octreotide; parenteral
512.7
43.8
42
*
JN3AD
NOMESCO Finland
Abdominal CT examination
8.4
43.3
70
117
TPH07
NOMESCO Finland
Cathetrisation of artery
8.5
42.9
68
111
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.4
42.6
60
85
D76
ICPC
Malignant neoplasm pancreas
+∞
42.1
39
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
40.9
38
*
XX3DW
NOMESCO Finland
Time consuming IT work
13.4
40.1
41
37
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
39.8
37
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
38.7
36
*
JN4CD
NOMESCO Finland
Very extensive body CT
60.9
38.3
44
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.8
37.4
49
63
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
214.5
35.9
36
*
Z51.5
ICD-10 Finland
Palliative care
14.8
34.8
33
26
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
34.3
32
*
WZC30
NOMESCO Finland
Teaching
6.3
32.6
69
149
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
32.1
30
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.3
31.4
65
137
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
49.1
31.1
37
9
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
49.1
31.1
37
9
H02AB02
ATC
dexamethasone; systemic
47.5
30.1
36
9
N02AA05
ATC
oxycodone; systemic
5.8
28.9
67
156
WZC00
NOMESCO Finland
Treatment plan or consultation
4.8
28.8
105
356
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
89.6
28.6
31
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
307.0
27.4
27
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
26.8
97
324
158
Kela drug reimbursment
Everolimus
+∞
26.6
25
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
26.6
25
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
293.8
26.3
26
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
293.8
26.3
26
*
197
Kela drug reimbursment
Sunitinib
+∞
25.5
24
*
B01AB05
ATC
enoxaparin; parenteral
4.3
25.0
106
395
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.7
24.8
55
122
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
23.3
22
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
+∞
21.2
20
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
21.2
20
*
8249/3-C25.2
ICD-O-3
Neuroendocrine tumor, grade 2 of tail of pancreas
+∞
21.2
20
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
81.0
20.1
22
*
JAH01
NOMESCO Finland
Laparoscopy
8.6
19.1
26
34
340
Kela drug reimbursment
Everolimus
+∞
19.0
18
*
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
19.0
18
*
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
19.0
18
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
19.0
18
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.6
18.9
98
404
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.6
18.6
92
367
A10AE04
ATC
insulin glargine; parenteral
4.7
18.3
49
126
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
18.0
17
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
18.0
17
*
B01AB04
ATC
dalteparin; parenteral
8.2
17.8
25
34
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.4
17.6
106
476
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
38.5
17.0
21
6
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.9
16
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
16.9
16
*
L01XE10
ATC
[U] everolimus
+∞
16.9
16
*
A10AB05
ATC
insulin aspart; parenteral
5.1
16.7
39
89
B01AB10
ATC
tinzaparin; parenteral
5.2
16.1
37
83
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
171.9
15.7
16
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
171.9
15.7
16
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
15.5
129
687
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
86.1
14.8
16
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
86.1
14.8
16
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
160.3
14.6
15
*
WX402
NOMESCO Finland
General anaesthesia
3.5
14.6
62
220
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
14.5
58
198
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
14.4
91
410
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
80.3
13.8
15
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
36.7
13.7
17
5
322
Kela drug reimbursment
Sunitinib
+∞
13.7
13
*
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
13.7
13
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
148.9
13.6
14
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
148.9
13.6
14
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
14.3
13.2
22
17
T90
ICPC
Diabetes non-insulin dependent
3.0
13.2
80
349
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
13.1
99
487
WF002
NOMESCO Finland
Radical radiotherapy
74.3
12.7
14
*
Z31.5
ICD-10 Finland
Genetic counselling
6.7
12.7
21
34
JAH00
NOMESCO Finland
Laparotomy
12.7
12.6
22
19
8249/3-C25.1
ICD-O-3
Neuroendocrine tumor, grade 2 of body of pancreas
+∞
12.6
12
*
L01XE04
ATC
[U] sunitinib
+∞
12.6
12
*
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
12.6
12
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
137.6
12.6
13
*
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
137.6
12.6
13
*
JKA20
NOMESCO Finland
Cholecystectomy
13.5
12.4
21
17
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
28.6
12.2
16
6
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
22.9
12.2
17
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
12.1
57
214
J01MA12
ATC
levofloxacin; systemic
3.2
11.9
56
210
L01CB01
ATC
etoposide; systemic
+∞
11.6
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
126.4
11.5
12
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.9
11.3
21
21
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
11.2
30
76
UJK02
NOMESCO Finland
ERCP
12.9
11.1
19
16
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
45.8
11.0
13
*
R4190
NOMESCO Finland
Nutritional therapy
11.5
11.0
20
19
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
11.0
35
101
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.2
10.7
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
115.4
10.5
11
*
WVA30, ,
SPAT
5.1
10.5
23
49
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.5
10
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.5
10
*
L01EG02
ATC
everolimus; oral
+∞
10.5
10
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
20.0
10.4
15
8
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
42.2
10.1
12
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.5
10.0
20
23
ZX120
NOMESCO Finland
Intravenous
4.5
10.0
26
64
A06AH03
ATC
naloxegol; oral
57.6
9.7
11
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
10.8
9.7
18
18
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
9.6
75
366
A11CC03
ATC
alfacalcidol; systemic
10.2
9.5
18
19
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
9.4
9
*
L01EX01
ATC
sunitinib; oral
+∞
9.4
9
*
8249/3-C25.0
ICD-O-3
Neuroendocrine tumor, grade 2 of head of pancreas
+∞
9.4
9
*
A10BA02
ATC
metformin; oral
2.5
9.4
85
443
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.6
9.4
34
107
SPAT1262
SPAT
Handing over of treatment supplies
2.8
9.3
56
238
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
16.5
9.2
14
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
9.1
60
268
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
25.3
9.0
12
5
WW500
NOMESCO Finland
Blood transfusion
14.9
8.8
14
10
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
14.9
8.8
14
10
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
52.1
8.7
10
*
106
Kela drug reimbursment
Hypoparathyroidism
52.1
8.7
10
*
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
52.1
8.7
10
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.6
8.7
17
19
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
17.2
8.7
13
8
L02BG04
ATC
letrozole; oral
21.1
8.6
12
6
K83.0
ICD-10 Finland
Cholangitis
28.8
8.6
11
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
8.5
52
222
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
93.5
8.5
9
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
93.5
8.5
9
*
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
93.5
8.5
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
8.4
93
526
JN4SR
NOMESCO Finland
Very extensive PET-CT of receptors in whole body
+∞
8.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.4
8
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
8.4
8
*
BBA50
NOMESCO Finland
Total parathyroidectomy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
8.4
8
*
Z3226
NOMESCO Finland
Physiotherapist
2.8
8.4
49
205
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.1
8.3
18
38
R4110
NOMESCO Finland
Physiotherapy
2.5
8.2
68
338
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
10.6
8.2
15
15
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.6
8.2
15
15
WX892
NOMESCO Finland
Monitored bed care
3.7
8.1
27
80
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
23.0
8.1
11
5
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
14.0
7.5
12
9
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
82.8
7.5
8
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
7.4
76
412
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
16.5
7.3
11
7
T89
ICPC
Diabetes insulin dependent
4.4
7.0
18
44
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
6.9
17
40
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
17.4
6.8
10
6
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
41.4
6.8
8
*
ZXC96
NOMESCO Finland
Robot assisted procedure
41.4
6.8
8
*
E21.2
ICD-10 Finland
Other hyperparathyroidism
41.4
6.8
8
*
A55
ICPC
General and Unspecified, Local injection/infiltration
23.4
6.7
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.1
6.7
19
50
N02AX02
ATC
tramadol; systemic, rectal
2.1
6.7
105
669
K86.8
ICD-10 Finland
Other specified diseases of pancreas
71.9
6.5
7
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
71.9
6.5
7
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
71.9
6.5
7
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
14.9
6.5
10
7
R10.0
ICD-10 Finland
Acute abdomen
7.4
6.3
14
20
HA1AA
NOMESCO Finland
X-ray mammography
7.4
6.3
14
20
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
18.7
6.3
9
5
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.2
6.3
17
43
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
+∞
6.3
6
*
8246/3-C25.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of tail of pancreas
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
+∞
6.3
6
*
N04BC06
ATC
cabergoline; oral
27.5
6.3
8
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.5
6.1
11
11
SPAT1254
SPAT
Administration of medicine
2.6
6.1
37
157
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
179
10
1017.47
307.65
9.3
2.1
41.82
3.56
nmol/l
—
179
10
116
92
25.94
130.59
3.6
1.4
7.19
2.51
ug/l
1.35
93
67
80
42
29.59
107.66
1.9
1.3
205.98
320.51
ug/g
2.34
69
22
66
39
23.88
83.34
3.2
1.6
655.80
9.52
u/ml
0.51
59
27
65
9
102.15
61.18
4.4
1.3
26.14
11.86
ug/l
—
65
9
49
44
14.09
48.41
2.2
1.2
0.72
0.92
nmol/l
0.72
49
36
171
684
8.08
42.45
10.2
3.4
34.75
36.04
g/l
2.62
166
630
176
797
7.40
35.74
12.4
13.8
1.22
1.35
inr
1.15
59
224
162
718
5.96
32.59
11.4
5.0
1.20
1.21
mmol/l
1.07
157
645
169
793
6.11
31.22
13.6
5.5
1.20
1.21
mmol/l
1.06
139
689
153
699
5.03
28.16
3.3
2.2
—
—
—
0
0
71
190
5.07
25.86
4.4
2.0
7.87
7.02
umol/l
0.13
63
162
64
157
5.36
25.82
3.7
2.0
122.05
31.19
u/l
0.98
57
129
180
994
5.76
24.44
9.0
3.9
7.19
6.70
mmol/l
2.55
175
919
68
199
4.52
21.80
7.5
5.3
104.85
104.17
mmol/l
0.55
68
199
163
934
3.99
18.52
21.1
5.9
4.17
4.23
e9/l
0.13
152
822
113
518
3.47
18.26
10.2
2.0
2.37
2.36
mmol/l
0.12
106
429
87
351
3.47
17.05
2.5
2.0
—
—
—
0
0
46
126
4.36
15.70
5.8
4.2
59.78
81.23
ng/l
1.47
38
107
58
198
3.63
14.47
2.5
2.3
20.04
23.95
%
1.22
49
169
54
181
3.64
13.80
8.4
6.2
1.60
1.46
mmol/l
0.10
47
145
23
39
6.48
13.36
2.8
2.2
4.87
5.55
mmol/24h
0.29
23
33
53
180
3.57
13.24
8.5
6.2
5.31
5.25
kpa
0.20
53
174
53
180
3.57
13.24
8.4
6.2
14.01
11.44
kpa
2.32
53
175
105
587
2.53
10.17
3.1
3.0
—
—
—
0
0
17
17
10.74
9.20
2.3
1.9
689.01
220.25
u/ml
0.28
17
17
63
291
2.64
8.90
7.4
2.0
2.48
2.43
mmol/l
1.99
56
245
16
22
7.76
7.33
1.1
1.2
—
—
—
0
0
37
144
2.89
7.16
3.6
3.3
131.30
221.02
ng/l
1.02
30
134
38
153
2.80
6.90
5.3
2.7
—
—
—
0
0
70
382
2.23
6.61
2.6
2.0
3.08
3.00
mg/l
0.08
61
314
10
7
14.89
6.46
1.5
1.4
32.00
28.86
umol/l
—
10
7
160
1217
2.20
6.12
5.8
3.0
86.90
48.00
u/l
1.50
153
1133
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
44
4.11
6.11
1.6
2.3
0.30
0.32
u/ml
—
9
24
77
449
2.11
6.08
3.4
2.8
0.36
0.40
e6/l
0.08
59
327
27
98
3.00
5.88
1.9
1.4
—
—
—
0
0
88
549
2.01
5.72
3.2
3.0
712.29
1040.42
ng/l
0.58
77
450
32
135
2.61
5.28
6.2
2.0
71.06
67.48
ml/min/173m2
0.26
18
52
16
36
4.71
5.17
1.8
1.4
—
—
—
0
0
70
439
1.88
4.27
4.0
3.5
0.00
0.00
estimate
-0.00
27
135
88
593
1.81
4.26
3.9
4.0
10.35
8.15
mg/mmol
0.22
61
373
202
1792
2.84
3.99
33.3
11.3
35.31
22.56
mg/l
5.40
188
1348
45
249
2.02
3.93
1.8
1.8
—
—
—
0
0
11
26
4.40
3.56
1.7
1.5
—
—
—
0
0
12
31
4.04
3.55
1.3
1.2
—
—
—
0
0
33
170
2.11
3.47
1.7
1.9
—
—
—
0
0
12
32
3.91
3.45
1.3
1.3
—
—
—
0
0
60
381
1.79
3.43
1.9
1.7
1.49
1.08
mg/l
0.91
48
292
33
171
2.10
3.42
1.6
1.8
—
—
—
0
0
9
18
5.17
3.41
1.3
1.2
—
—
—
0
0
98
716
1.67
3.38
4.1
3.5
35.84
40.23
ng/l
0.10
78
507
12
33
3.79
3.35
1.3
1.2
—
—
—
0
0
11
28
4.08
3.34
3.8
1.9
15.18
17.53
%
—
5
10
6
8
7.67
3.07
1.3
1.1
—
—
—
0
0
7
12
5.99
3.04
1.3
1.2
—
—
—
0
0
178
1547
1.84
3.00
38.0
13.4
15.57
14.98
%
0.69
178
1518
90
662
1.61
2.92
4.3
3.5
—
—
—
0
0
193
1734
2.02
2.75
30.0
10.4
82.45
80.17
ml/min/173m2
0.90
183
1398
8
19
4.33
2.70
1.3
1.2
—
—
—
0
0
20
94
2.24
2.64
1.8
1.4
—
—
—
0
0
105
826
1.53
2.43
5.3
4.8
0.00
0.00
estimate
-0.00
30
140
105
827
1.52
2.41
4.1
3.5
0.00
0.00
estimate
-0.00
32
150
154
1320
1.57
2.37
3.6
4.1
13.02
10.66
mm/h
0.91
138
1200
106
839
1.51
2.36
4.1
3.5
0.00
0.00
estimate
-0.00
29
135
9
28
3.31
2.33
3.3
3.3
56.22
57.21
%
—
9
28
7
18
3.98
2.27
1.6
1.3
—
—
—
0
0
41
262
1.70
2.25
2.6
2.9
1.78
2.21
e6/l
0.21
18
135
8
24
3.42
2.20
1.3
1.1
—
—
—
0
0
55
387
1.56
2.06
1.6
1.8
462.11
428.95
pmol/l
0.22
44
316
6
15
4.08
2.05
1.2
1.3
—
—
—
0
0
21
113
1.95
2.00
5.9
4.1
5.47
5.24
kpa
0.64
21
108
7
22
3.25
1.89
1.6
1.3
—
—
—
0
0
93
743
1.44
1.86
2.2
1.9
86.71
95.17
pmol/l
1.08
58
390
6
17
3.60
1.85
1.7
1.4
—
—
—
0
0
27
168
1.69
1.65
3.6
3.0
5.66
5.81
kpa
0.46
27
160
27
168
1.69
1.65
3.6
3.0
1.80
2.20
mmol/l
0.14
21
131
23
137
1.76
1.63
3.9
2.6
4.79
4.35
kpa
0.37
23
128
41
285
1.54
1.61
2.4
2.7
0.75
0.96
e6/l
0.29
18
157
181
1662
1.54
1.55
5.4
4.6
1.96
2.67
mu/l
0.47
166
1509
7
29
2.46
1.40
1.1
1.1
—
—
—
0
0
46
339
1.45
1.38
1.8
1.8
1312.50
1130.35
nmol/l
0.51
39
257
5
17
2.98
1.36
1.2
1.4
—
—
—
0
0
5
17
2.98
1.36
1.2
1.4
—
—
—
0
0
6
24
2.54
1.31
1.2
1.3
—
—
—
0
0
6
24
2.54
1.31
1.2
1.3
—
—
—
0
0
149
1340
1.36
1.27
5.0
3.8
14.54
14.84
pmol/l
0.73
143
1207
9
167
0.52
1.25
2.0
1.8
—
—
—
0
0
15
86
1.80
1.22
1.3
1.7
—
—
—
0
0
192
1816
1.50
1.09
7.3
4.5
6.78
5.99
mmol/l
6.87
186
1643
15
90
1.72
1.07
2.8
2.1
0.91
1.33
%
1.20
15
90
14
87
1.65
0.90
2.8
2.1
0.69
0.64
%
0.20
14
87
21
291
0.69
0.83
1.1
1.2
1.46
9.25
u/ml
—
10
110
57
474
1.27
0.80
2.3
2.4
358.29
6934.82
umol/l
2.05
48
410
48
391
1.29
0.79
4.1
3.6
1.01
1.02
kg/l
2.41
11
59
44
355
1.30
0.78
3.8
3.6
127.38
338.32
ng/l
0.84
32
284
12
75
1.64
0.76
7.3
4.8
25.08
25.11
mmol/l
0.01
12
67
5
26
1.94
0.71
1.2
1.8
—
—
—
0
0
8
50
1.62
0.62
2.0
4.4
—
—
—
0
0
8
51
1.59
0.61
1.8
1.3
—
—
—
0
0
27
213
1.31
0.57
1.6
1.3
—
—
—
0
0
206
2011
1.48
0.56
50.6
16.8
38.60
40.77
%
5.74
199
1881
114
1055
1.17
0.52
2.8
3.0
—
—
—
0
0
21
165
1.30
0.47
2.2
2.4
6.04
8.05
ug/l
0.30
21
144
7
50
1.41
0.45
1.4
1.6
—
—
—
0
0
11
151
0.71
0.44
2.6
1.9
—
—
—
0
0
10
139
0.71
0.43
2.6
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
2.4
—
13.31
—
0
17
8
60
1.35
0.40
1.6
1.6
—
—
—
0
0
5
34
1.48
0.40
1.8
2.2
104.00
105.41
mmol/l
—
5
34
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
5
37
1.36
0.37
3.2
1.8
116.80
128.99
g/l
—
5
22
9
70
1.30
0.37
1.0
1.2
—
—
—
0
0
78
726
1.12
0.30
4.2
3.7
2.15
1.90
ug/l
0.41
67
653
8
63
1.28
0.28
1.5
1.7
—
—
—
0
0
8
65
1.24
0.27
1.8
1.6
—
—
—
0
0
27
308
0.86
0.26
1.1
1.3
16.18
34.16
iu/ml
—
9
99
26
227
1.17
0.25
17.1
6.5
—
—
—
0
0
6
82
0.72
0.24
1.0
1.3
—
—
—
0
0
181
1772
1.13
0.23
4.4
4.1
1.44
1.28
mmol/l
1.48
171
1620
5
40
1.26
0.22
1.2
1.1
—
16.97
—
0
6
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
262.60
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
27
243
1.13
0.18
4.0
5.0
32.65
31.16
%
0.23
20
163
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
39
366
1.08
0.13
1.6
1.3
2.71
2.08
u/ml
0.14
13
108
6
54
1.11
0.09
1.3
1.4
—
—
—
0
0
6
56
1.07
0.08
1.3
1.6
—
—
—
0
0
11
120
0.91
0.05
1.0
1.3
—
26.00
—
0
9
40
413
0.96
0.05
2.9
2.5
0.85
0.73
ug/l
0.40
25
255
189
1878
1.05
0.04
5.0
5.2
2.51
2.75
mmol/l
2.93
177
1732
58
571
1.02
0.02
3.4
3.6
24.44
23.96
%
0.08
30
245
29
283
1.03
0.01
1.3
1.6
—
—
—
0
0
184
1833
1.03
0.01
4.5
4.6
1.35
1.45
mmol/l
2.48
175
1689
185
1845
1.02
0.00
4.8
4.6
4.32
4.63
mmol/l
3.82
176
1710
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
26.58
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
5.71
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
9.47
—
0
6
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).